Drugs / pVAXrcPSAv53l
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00859729 | Dec 2008 → Nov 2011 | prostate cancer | Uppsala University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pVAXrcPSAv53l | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00859729 ↗ |
| Modality | Vaccine | “DNA Vaccine” NCT00859729 ↗ |
| Route | Other | “administered intradermally” NCT00859729 ↗ |